Literature DB >> 20457229

Longitudinal analysis of the behavioural phenotype in HdhQ92 Huntington's disease knock-in mice.

Simon Brooks1, Gemma Higgs, Lesley Jones, Stephen B Dunnett.   

Abstract

Huntington's disease is caused by a single mutation resulting in an expanded polyglutamine sequence which causes the production of a mutant variant of the protein huntingtin, which is ultimately responsible for the motor, cognitive and emotional symptoms and early death of the individual. Several mouse models have been created that seek to recapitulate the features of the disease. The present study sought to characterise the Hdh(Q92) mouse line longitudinally, to determine the nature, extent and age of onset of any behavioural deficits. On each of the tests used the Hdh(Q92/Q92) mice demonstrated poorer performance than their wildtype littermates, and these performance deficits were age dependent. Of the tests applied acoustic startle and prepulse inhibition proved to be the most sensitive with differences between the mouse groups appearing ∼4 months of age, an age where grip strength differences were also found. Male Hdh(Q92/Q92) mice started losing weight relative their wildtype littermates from 10 months of age, and water maze performance began to deteriorate from 14 months. There were slight differences in rotarod ability with advancing age, with the Hdh(Q92/Q92) demonstrating greater variability in performance than their wildtype littermates. Analysis of body weight and the initial stage of the water maze procedure produced clear between group differences, whereas the grip strength, rotarod and acoustic startle tests demonstrated significance only when age was a factor in the analyses, suggesting that changes in the pattern of performance over time were responsible for the differences, rather than overall group effects per se. The results highlight the necessity for the longitudinal assessment of mouse lines to detect subtle behavioural differences experimental groups.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20457229     DOI: 10.1016/j.brainresbull.2010.05.003

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  8 in total

1.  Large-scale phenome analysis defines a behavioral signature for Huntington's disease genotype in mice.

Authors:  Vadim Alexandrov; Dani Brunner; Liliana B Menalled; Andrea Kudwa; Judy Watson-Johnson; Matthew Mazzella; Ian Russell; Melinda C Ruiz; Justin Torello; Emily Sabath; Ana Sanchez; Miguel Gomez; Igor Filipov; Kimberly Cox; Mei Kwan; Afshin Ghavami; Sylvie Ramboz; Brenda Lager; Vanessa C Wheeler; Jeff Aaronson; Jim Rosinski; James F Gusella; Marcy E MacDonald; David Howland; Seung Kwak
Journal:  Nat Biotechnol       Date:  2016-07-04       Impact factor: 54.908

2.  Similar striatal gene expression profiles in the striatum of the YAC128 and HdhQ150 mouse models of Huntington's disease are not reflected in mutant Huntingtin inclusion prevalence.

Authors:  Zubeyde Bayram-Weston; Timothy C Stone; Peter Giles; Linda Elliston; Nari Janghra; Gemma V Higgs; Peter A Holmans; Stephen B Dunnett; Simon P Brooks; Lesley Jones
Journal:  BMC Genomics       Date:  2015-12-21       Impact factor: 3.969

3.  A Longitudinal Operant Assessment of Cognitive and Behavioural Changes in the HdhQ111 Mouse Model of Huntington's Disease.

Authors:  Emma Yhnell; Stephen B Dunnett; Simon P Brooks
Journal:  PLoS One       Date:  2016-10-04       Impact factor: 3.240

4.  Potential molecular consequences of transgene integration: The R6/2 mouse example.

Authors:  Jessie C Jacobsen; Serkan Erdin; Colby Chiang; Carrie Hanscom; Renee R Handley; Douglas D Barker; Alex Stortchevoi; Ian Blumenthal; Suzanne J Reid; Russell G Snell; Marcy E MacDonald; A Jennifer Morton; Carl Ernst; James F Gusella; Michael E Talkowski
Journal:  Sci Rep       Date:  2017-01-25       Impact factor: 4.379

Review 5.  Mouse models of polyglutamine diseases: review and data table. Part I.

Authors:  Maciej Figiel; Wojciech J Szlachcic; Pawel M Switonski; Agnieszka Gabka; Wlodzimierz J Krzyzosiak
Journal:  Mol Neurobiol       Date:  2012-09-07       Impact factor: 5.590

6.  Correlations of behavioral deficits with brain pathology assessed through longitudinal MRI and histopathology in the R6/1 mouse model of Huntington's disease.

Authors:  Ivan Rattray; Edward J Smith; William R Crum; Thomas A Walker; Richard Gale; Gillian P Bates; Michel Modo
Journal:  PLoS One       Date:  2013-12-19       Impact factor: 3.240

7.  A broad phenotypic screen identifies novel phenotypes driven by a single mutant allele in Huntington's disease CAG knock-in mice.

Authors:  Sabine M Hölter; Mary Stromberg; Marina Kovalenko; Lillian Garrett; Lisa Glasl; Edith Lopez; Jolene Guide; Alexander Götz; Wolfgang Hans; Lore Becker; Birgit Rathkolb; Jan Rozman; Anja Schrewed; Martin Klingenspor; Thomas Klopstock; Holger Schulz; Eckhard Wolf; Wolfgang Wursta; Tammy Gillis; Hiroko Wakimoto; Jonathan Seidman; Marcy E MacDonald; Susan Cotman; Valérie Gailus-Durner; Helmut Fuchs; Martin Hrabě de Angelis; Jong-Min Lee; Vanessa C Wheeler
Journal:  PLoS One       Date:  2013-11-22       Impact factor: 3.240

8.  Impaired Performance of the Q175 Mouse Model of Huntington's Disease in the Touch Screen Paired Associates Learning Task.

Authors:  Tuukka O Piiponniemi; Teija Parkkari; Taneli Heikkinen; Jukka Puoliväli; Larry C Park; Roger Cachope; Maksym V Kopanitsa
Journal:  Front Behav Neurosci       Date:  2018-10-02       Impact factor: 3.558

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.